In addition to the pre-treatment serum CRP/ALB or ALB/CRP ratio, a high post-treatment serum, high-sensitivity CRP (hsCRP)/ALB ratio was shown in a study conducted by Oh et al. [48] to independently predict worse OS and RFS in HCC patients receiving curative surgical resection. Here, CRP is linked to hepatocellular carcinoma.